Elevance Health Inc (NYSE: ELV) is -35.63% lower on its value in year-to-date trading and has touched a low of $339.39 and a high of $567.26 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The ELV stock was last observed hovering at around $345.86 in the last trading session, with the day’s loss setting it -5.19%.
Currently trading at $340.67, the stock is -7.46% and -11.22% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.7 million and changing -1.50% at the moment leaves the stock -16.68% off its SMA200. ELV registered -7.65% loss for a year compared to 6-month gain of -10.53%. The firm has a 50-day simple moving average (SMA 50) of $383.7118 and a 200-day simple moving average (SMA200) of $408.872.
The stock witnessed a -11.27% loss in the last 1 month and extending the period to 3 months gives it a -21.81%, and is -2.06% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 1.98% over the week and 2.39% over the month.
Elevance Health Inc (ELV) has around 104200 employees, a market worth around $76.97B and $183.12B in sales. Current P/E ratio is 13.29 and Fwd P/E is 8.75. Profit margin for the company is 3.23%. Distance from 52-week low is 0.38% and -39.94% from its 52-week high. The company has generated returns on investments over the last 12 months (8.38%).
The EPS is expected to grow by 3.79% this year.
Elevance Health Inc (ELV) Top Institutional Holders
2230.0 institutions hold shares in Elevance Health Inc (ELV), with institutional investors hold 93.23% of the company’s shares. The shares outstanding are 225.64M, and float is at 225.56M with Short Float at 1.13%. Institutions hold 93.07% of the Float.
The top institutional shareholder in the company is VANGUARD GROUP INC with over 21.21 million shares valued at $11.49 billion. The investor’s holdings represent 9.133% of the ELV Shares outstanding. As of 2024-06-30, the second largest holder is BLACKROCK INC. with 20.7 million shares valued at $11.22 billion to account for 8.9168 of the shares outstanding. The other top investors are PRICE T ROWE ASSOCIATES INC /MD/ which holds 11.65 million shares representing 5.0157% and valued at over $6.31 billion, while STATE STREET CORP holds 4.5471 of the shares totaling 10.56 million with a market value of $5.72 billion.
Elevance Health Inc (ELV) Insider Activity
The most recent transaction is an insider sale by Kaye Mark,the company’sEVP & CFO. SEC filings show that Kaye Mark sold 4,588 shares of the company’s common stock on Apr 24 ’25 at a price of $424.82 per share for a total of $1.95 million. Following the sale, the insider now owns 18977.0 shares.
Still, SEC filings show that on Mar 10 ’25, Penczek Ronald W (CAO & Controller) disposed off 443 shares at an average price of $415.13 for $0.18 million. The insider now directly holds 1,847 shares of Elevance Health Inc (ELV).
